Related Experiment Video
Updated: May 12, 2026
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
Molecular diagnostic methods for rapid diagnosis of central nervous system infections
Mallikarjuna Pedduru Venkatareddy1, Dinesh Upadhya2, Prakash Peralam Yegneswaran3
1Department of Medical Laboratory Technology, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Abstract:
Central nervous system infections (CNSI) are serious life-threatening conditions caused by bacteria, viruses, fungi, and parasites and lead to high morbidity and mortality worldwide. Therefore, rapid identification of causative organisms and appropriate treatment are important. The traditional identification methods are time-consuming and lack sensitivity and specificity. Although culture method is gold standard for CNSI, it is time-consuming and microbiology reporting requires several days. Multiplex PCR assays can detect multiple pathogens simultaneously in clinical samples and overcome the limitations of conventional identification techniques. Despite the availability of several commercial molecular-based platforms for the detection of pathogens causing CNSI, there are still limitations in terms of cost, false positive results, and false negative results, which are limited to targeted pathogens in the panel. Moreover, validation of many commercially available and in-house laboratory-developed molecular assays is still lacking. In addition, molecular diagnostic tests need to be used in correlation with the clinical context to ensure better diagnosis and management of infections.
Insights
Rapidly identifying pathogens causing central nervous system infections (CNSI) is crucial. Multiplex PCR assays offer faster detection than traditional methods, but require careful validation and clinical correlation for accurate diagnosis and treatment.
Area of Science:
- Infectious Diseases
- Molecular Diagnostics
- Neuroscience
Background:
- Central nervous system infections (CNSI) present a significant global health challenge, characterized by high morbidity and mortality.
- Traditional diagnostic methods for CNSI, including culture, are often slow and lack sufficient sensitivity and specificity.
- Timely identification of causative pathogens is critical for effective treatment and improved patient outcomes.
Purpose of the Study:
- To highlight the limitations of conventional diagnostic techniques for CNSI.
- To introduce multiplex PCR assays as a rapid alternative for pathogen detection.
- To discuss the challenges and considerations for implementing molecular diagnostic tests in clinical settings.
Main Methods:
- Review of traditional microbiological identification methods for CNSI.
- Evaluation of multiplex PCR assays for simultaneous detection of multiple pathogens.
- Discussion of limitations associated with commercial and in-house molecular platforms.
Main Results:
- Multiplex PCR assays demonstrate potential for faster and broader pathogen detection compared to traditional methods.
- Current molecular platforms face challenges including cost, potential for false results, and limited pathogen targets.
- Validation of molecular assays and integration with clinical context are essential for reliable diagnosis.
Conclusions:
- Multiplex PCR assays represent an advancement in diagnosing CNSI, offering speed and multiplexing capabilities.
- Addressing limitations such as cost, accuracy, and panel scope is necessary for widespread adoption.
- Molecular diagnostics for CNSI must be interpreted alongside clinical findings for optimal patient management.
More Related Videos
Related Concept Videos
01:28Methods of Classification and Identification
01:24Automated Microbial Diagnostics
01:18Viral Meningitis